EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-threshold–guided adaptive cancer therapy with partial-cycle treatment: A mechanistic and reinforcement learning analysis

Kexin Ma, Ningjing Wang, Zai Yang, Robert A Cheke iD, Biao Tang iD

PLOS Computational Biology · 2026

DOI: 10.1371/journal.pcbi.1014457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, 2026. Verfasst von Kexin Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, People's Republic of China. Hauptthemen laut MEDLINE: Neoplasms, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Technologies Research and Development Program, National Natural Science Foundation of China, Young Talent Support Plan of Xi’an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adaptive cancer therapy seeks to modulate aggressive treatment to preserve drug-sensitive tumor cells that suppress resistant populations, but existing strategies often rely on frequent treatment decisions enabled by intensive surveillance, limiting clinical feasibility. Here, we propose a clinically motivated alternative that shortens the treatment window within a fixed and relatively long surveillance cycle, thereby avoiding the need for frequent monitoring. Based on this idea, we develop a mechanistic modeling framework for single-threshold-guided adaptive therapy with partial surveillance-cycle treatment (AT-PSC) and benchmark its performance using reinforcement learning. Using clinically calibrated parameters from an individual patient, simulations show that AT-PSC prolongs the time to progression (TTP) by 402 days compared with adaptive therapy using full surveillance-cycle treatment, while substantially reducing treatment exposure (dose reduced by 10.1%). Consequently, AT-PSC achieves significantly larger TTP gains than continuous therapy (1891 days) and two-threshold-guided adaptive therapy AT50 (1123 days). Simulations using data from six additional patients and sensitivity analyses further demonstrate that these benefits are robust across heterogeneous tumor growth profiles, while individual-based treatment should be considered to maximize TTP. Reinforcement learning yields comparable outcomes under the same fixed treatment window and can further extend TTP when the treatment window is adaptively adjusted. Together, these results support AT-PSC as a clinically feasible strategy to improve disease control while reducing treatment burden, and suggest that a practical regimen, such as a 14-day treatment window within a 30-day surveillance cycle, can provide sustained benefits for a broad patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsModels, BiologicalHumansReinforcement Machine LearningComputer SimulationComputational BiologyAdaptive AlgorithmsAntineoplastic Agents

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, People's Republic of China.
  • Natural Resources Institute, University of Greenwich at Medway, Central Avenue, Chatham Maritime, Kent, United Kingdom.
  • Department of Infectious Disease Epidemiology, Imperial College London, School of Public Health, White City Campus, London, United Kingdom.
  • The Interdisciplinary Research Center for Mathematics and Life Sciences, Xi'an Jiaotong University, Xi'an, People's Republic of China.

ORCID-Profile: Robert A Cheke, Biao Tang

Förderung

  • Key Technologies Research and Development Program
  • National Natural Science Foundation of China
  • Young Talent Support Plan of Xi’an Jiaotong University

Zitieren

APA

Ma, K., Wang, N., Yang, Z., Cheke, R. A., & Tang, B. (2026). Single-threshold–guided adaptive cancer therapy with partial-cycle treatment: A mechanistic and reinforcement learning analysis. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1014457

Vancouver

Ma K, Wang N, Yang Z, Cheke RA, Tang B. Single-threshold–guided adaptive cancer therapy with partial-cycle treatment: A mechanistic and reinforcement learning analysis. PLOS Computational Biology. 2026. doi:10.1371/journal.pcbi.1014457

BibTeX
@article{Ma2026,
  author = {Ma, Kexin and Wang, Ningjing and Yang, Zai and Cheke, Robert A and Tang, Biao},
  title = {Single-threshold–guided adaptive cancer therapy with partial-cycle treatment: A mechanistic and reinforcement learning analysis},
  journal = {PLOS Computational Biology},
  year = {2026},
  doi = {10.1371/journal.pcbi.1014457}
}
Kostenlos starten →